ArticleJournal of clinical and experimental hematopathology : JCEH2019
Phase I study of ibrutinib in Japanese patients with treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma.
Hirohiko Shibayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.